Equities

Lyka Labs Ltd

LYKALABS:NSI

Lyka Labs Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (INR)152.90
  • Today's Change-4.61 / -2.93%
  • Shares traded112.02k
  • 1 Year change+36.58%
  • Beta1.4045
Data delayed at least 15 minutes, as of Sep 18 2024 11:17 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Key statistics

On Wednesday, Lyka Labs Ltd (LYKALABS:NSI) closed at 152.90, -11.36% below its 52-week high of 172.50, set on Sep 06, 2024.
52-week range
Today
97.90Jun 04 2024172.50Sep 06 2024
Open157.50
High158.48
Low152.00
Bid152.00
Offer152.90
Previous close157.51
Average volume502.43k
Shares outstanding35.69m
Free float14.13m
P/E (TTM)866.92
Market cap5.65bn INR
EPS (TTM)0.1826
INR
Data delayed at least 15 minutes, as of Sep 18 2024 11:17 BST.
More ▼

Events & Activity

  • LYKALABS:NSI price moved over +1.32% to 157.00
  • LYKALABS:NSI price falls below 15-day moving average to 154.61 at 03:07 BST
  • LYKALABS:NSI price falls below 15-day moving average to 153.80 at 03:12 BST
  • LYKALABS:NSI price falls below 15-day moving average to 153.21 at 01:24 BST
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
S&P Global Market Intelligence Short Selling Activity © S&P Global Market Intelligence. All rights reserved.
Although S&P Global Market Intelligence has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of S&P Global Market Intelligence on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.